Accuray (ARAY) Competitors $2.32 +0.10 (+4.50%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$2.33 +0.01 (+0.22%) As of 04:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, SYK, BSX, and MDTShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Accuray vs. Orthofix Medical Surmodics AngioDynamics Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Stryker Boston Scientific Medtronic Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has higher valuation & earnings, ARAY or OFIX? Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$446.55M0.52-$15.55M-$0.17-13.65Orthofix Medical$784.25M0.91-$151.40M-$3.13-5.96 Does the MarketBeat Community favor ARAY or OFIX? Orthofix Medical received 82 more outperform votes than Accuray when rated by MarketBeat users. However, 65.61% of users gave Accuray an outperform vote while only 61.98% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformAccurayOutperform Votes33265.61% Underperform Votes17434.39% Orthofix MedicalOutperform Votes41461.98% Underperform Votes25438.02% Is ARAY or OFIX more profitable? Accuray has a net margin of -3.72% compared to Orthofix Medical's net margin of -15.18%. Orthofix Medical's return on equity of -21.25% beat Accuray's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-3.72% -36.93% -3.52% Orthofix Medical -15.18%-21.25%-13.29% Does the media prefer ARAY or OFIX? In the previous week, Orthofix Medical had 3 more articles in the media than Accuray. MarketBeat recorded 6 mentions for Orthofix Medical and 3 mentions for Accuray. Orthofix Medical's average media sentiment score of 0.92 beat Accuray's score of 0.38 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accuray 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Orthofix Medical 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend ARAY or OFIX? Accuray presently has a consensus target price of $9.00, indicating a potential upside of 287.93%. Orthofix Medical has a consensus target price of $23.33, indicating a potential upside of 25.11%. Given Accuray's stronger consensus rating and higher possible upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more risk & volatility, ARAY or OFIX? Accuray has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Do insiders and institutionals hold more shares of ARAY or OFIX? 64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by company insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryAccuray and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks. Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$233.32M$4.88B$5.61B$9.14BDividend YieldN/A52.56%5.36%3.98%P/E Ratio-13.6526.4289.6917.66Price / Sales0.5253.761,219.4081.09Price / CashN/A52.0644.3437.71Price / Book5.168.245.134.73Net Income-$15.55M$13.79M$118.85M$225.42M7 Day Performance1.31%0.19%1.87%-0.44%1 Month Performance29.61%9.80%7.96%3.57%1 Year Performance-14.07%45.36%26.70%19.20% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray4.4714 of 5 stars$2.32+4.5%$9.00+287.9%-14.1%$233.32M$446.55M-13.651,040Upcoming EarningsShort Interest ↑OFIXOrthofix Medical3.7255 of 5 stars$18.34-0.1%$23.33+27.3%+31.9%$700.58M$746.64M-5.861,634Analyst UpgradeShort Interest ↓SRDXSurmodics4.3688 of 5 stars$37.90-0.7%$50.00+31.9%+1.5%$541.52M$126.08M-46.78450Earnings ReportUpcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageANGOAngioDynamics4.0157 of 5 stars$12.18-0.1%$13.00+6.7%+108.7%$492.88M$303.91M-2.16760Short Interest ↓RMTIRockwell Medical4.3669 of 5 stars$2.06-6.6%$6.00+192.0%+45.8%$66.42M$83.61M-41.10300Gap DownRSLSReShape Lifesciences0.9554 of 5 stars$4.36-1.9%N/A-69.5%$3.18M$8.68M0.0050Short Interest ↓ABTAbbott Laboratories4.9056 of 5 stars$129.38+3.5%$133.06+2.8%+13.5%$223.73B$41.95B16.86114,000Short Interest ↑ISRGIntuitive Surgical4.703 of 5 stars$573.67-1.8%$613.10+6.9%+53.8%$204.33B$7.12B92.2313,676Insider TradeShort Interest ↑SYKStryker4.8912 of 5 stars$398.27+1.0%$405.80+1.9%+23.2%$151.29B$20.50B42.5452,000Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsBSXBoston Scientific4.766 of 5 stars$102.04+0.1%$97.26-4.7%+67.6%$150.41B$14.24B84.3448,000Upcoming EarningsAnalyst UpgradeShort Interest ↑Positive NewsMDTMedtronic4.8535 of 5 stars$92.20+2.2%$95.00+3.0%+5.8%$118.03B$32.36B28.1595,000Short Interest ↓Positive News Related Companies and Tools Related Companies OFIX Alternatives SRDX Alternatives ANGO Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives SYK Alternatives BSX Alternatives MDT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ARAY) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.